Regulatory T cell therapy has shown some success therapeutically in the context of autoimmunity and transplantation. Here the authors explore the impact of IL-6, TGF-β and IL-2 on pathogenic Th17 cell generation post regulatory T cell therapy, and show therapeutic blockade of IL-6/STAT3 can reduce their generation in murine models of inflammatory disease.
- Hao Cheng
- Fang Nan
- Dunfang Zhang